Global Cannabis Use Disorder Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Cannabis Use Disorder Treatment Market Growth (Status and Outlook) 2025-2031

The global Cannabis Use Disorder Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Cannabis Use Disorder Treatment Industry Forecast looks at past sales and reviews total world Cannabis Use Disorder Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Cannabis Use Disorder Treatment sales for 2025 through 2031. With Cannabis Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis Use Disorder Treatment industry. This Insight Report provides a comprehensive analysis of the global Cannabis Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cannabis Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Cannabis Use Disorder Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis Use Disorder Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis Use Disorder Treatment market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Tobacco/Nicotine and Vaping &nbsp;&nbsp;&nbsp; Alcohol &nbsp;&nbsp;&nbsp; Marijuana &nbsp;&nbsp;&nbsp; Synthetic Cannabinoids &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals and Clinics &nbsp;&nbsp;&nbsp; Rehabilitation Centers &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Alkermes &nbsp;&nbsp;&nbsp; BioCorRx &nbsp;&nbsp;&nbsp; Cipla Limited &nbsp;&nbsp;&nbsp; Dr. Reddys Laboratories &nbsp;&nbsp;&nbsp; Glenmark Pharmaceuticals Limited &nbsp;&nbsp;&nbsp; Intas Pharmaceuticals Limited &nbsp;&nbsp;&nbsp; Indivior &nbsp;&nbsp;&nbsp; Mallinckrodt &nbsp;&nbsp;&nbsp; Noramco &nbsp;&nbsp;&nbsp; Orexo AB &nbsp;&nbsp;&nbsp; Purdue Pharma

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Cannabis Use Disorder Treatment Market Size (2020-2031) &nbsp;2.1.2 Cannabis Use Disorder Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Cannabis Use Disorder Treatment by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Cannabis Use Disorder Treatment Segment by Type &nbsp;2.2.1 Tobacco/Nicotine and Vaping &nbsp;2.2.2 Alcohol &nbsp;2.2.3 Marijuana &nbsp;2.2.4 Synthetic Cannabinoids &nbsp;2.2.5 Others &nbsp;2.3 Cannabis Use Disorder Treatment Market Size by Type &nbsp;2.3.1 Cannabis Use Disorder Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Cannabis Use Disorder Treatment Market Size Market Share by Type (2020-2025) &nbsp;2.4 Cannabis Use Disorder Treatment Segment by Application &nbsp;2.4.1 Hospitals and Clinics &nbsp;2.4.2 Rehabilitation Centers &nbsp;2.4.3 Others &nbsp;2.5 Cannabis Use Disorder Treatment Market Size by Application &nbsp;2.5.1 Cannabis Use Disorder Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Cannabis Use Disorder Treatment Market Size Market Share by Application (2020-2025) 3 Cannabis Use Disorder Treatment Market Size by Player &nbsp;3.1 Cannabis Use Disorder Treatment Market Size Market Share by Player &nbsp;3.1.1 Global Cannabis Use Disorder Treatment Revenue by Player (2020-2025) &nbsp;3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Cannabis Use Disorder Treatment Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Cannabis Use Disorder Treatment by Region &nbsp;4.1 Cannabis Use Disorder Treatment Market Size by Region (2020-2025) &nbsp;4.2 Global Cannabis Use Disorder Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Cannabis Use Disorder Treatment Market Size Growth (2020-2025) &nbsp;4.4 APAC Cannabis Use Disorder Treatment Market Size Growth (2020-2025) &nbsp;4.5 Europe Cannabis Use Disorder Treatment Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Cannabis Use Disorder Treatment Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Cannabis Use Disorder Treatment Market Size by Country (2020-2025) &nbsp;5.2 Americas Cannabis Use Disorder Treatment Market Size by Type (2020-2025) &nbsp;5.3 Americas Cannabis Use Disorder Treatment Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Cannabis Use Disorder Treatment Market Size by Region (2020-2025) &nbsp;6.2 APAC Cannabis Use Disorder Treatment Market Size by Type (2020-2025) &nbsp;6.3 APAC Cannabis Use Disorder Treatment Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Cannabis Use Disorder Treatment Market Size by Country (2020-2025) &nbsp;7.2 Europe Cannabis Use Disorder Treatment Market Size by Type (2020-2025) &nbsp;7.3 Europe Cannabis Use Disorder Treatment Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Cannabis Use Disorder Treatment by Region (2020-2025) &nbsp;8.2 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Cannabis Use Disorder Treatment Market Forecast &nbsp;10.1 Global Cannabis Use Disorder Treatment Forecast by Region (2026-2031) &nbsp;10.1.1 Global Cannabis Use Disorder Treatment Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Cannabis Use Disorder Treatment Forecast &nbsp;10.1.3 APAC Cannabis Use Disorder Treatment Forecast &nbsp;10.1.4 Europe Cannabis Use Disorder Treatment Forecast &nbsp;10.1.5 Middle East & Africa Cannabis Use Disorder Treatment Forecast &nbsp;10.2 Americas Cannabis Use Disorder Treatment Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Cannabis Use Disorder Treatment Forecast &nbsp;10.2.2 Canada Market Cannabis Use Disorder Treatment Forecast &nbsp;10.2.3 Mexico Market Cannabis Use Disorder Treatment Forecast &nbsp;10.2.4 Brazil Market Cannabis Use Disorder Treatment Forecast &nbsp;10.3 APAC Cannabis Use Disorder Treatment Forecast by Region (2026-2031) &nbsp;10.3.1 China Cannabis Use Disorder Treatment Market Forecast &nbsp;10.3.2 Japan Market Cannabis Use Disorder Treatment Forecast &nbsp;10.3.3 Korea Market Cannabis Use Disorder Treatment Forecast &nbsp;10.3.4 Southeast Asia Market Cannabis Use Disorder Treatment Forecast &nbsp;10.3.5 India Market Cannabis Use Disorder Treatment Forecast &nbsp;10.3.6 Australia Market Cannabis Use Disorder Treatment Forecast &nbsp;10.4 Europe Cannabis Use Disorder Treatment Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Cannabis Use Disorder Treatment Forecast &nbsp;10.4.2 France Market Cannabis Use Disorder Treatment Forecast &nbsp;10.4.3 UK Market Cannabis Use Disorder Treatment Forecast &nbsp;10.4.4 Italy Market Cannabis Use Disorder Treatment Forecast &nbsp;10.4.5 Russia Market Cannabis Use Disorder Treatment Forecast &nbsp;10.5 Middle East & Africa Cannabis Use Disorder Treatment Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Cannabis Use Disorder Treatment Forecast &nbsp;10.5.2 South Africa Market Cannabis Use Disorder Treatment Forecast &nbsp;10.5.3 Israel Market Cannabis Use Disorder Treatment Forecast &nbsp;10.5.4 Turkey Market Cannabis Use Disorder Treatment Forecast &nbsp;10.6 Global Cannabis Use Disorder Treatment Forecast by Type (2026-2031) &nbsp;10.7 Global Cannabis Use Disorder Treatment Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Cannabis Use Disorder Treatment Forecast 11 Key Players Analysis &nbsp;11.1 AbbVie &nbsp;11.1.1 AbbVie Company Information &nbsp;11.1.2 AbbVie Cannabis Use Disorder Treatment Product Offered &nbsp;11.1.3 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 AbbVie Main Business Overview &nbsp;11.1.5 AbbVie Latest Developments &nbsp;11.2 Alkermes &nbsp;11.2.1 Alkermes Company Information &nbsp;11.2.2 Alkermes Cannabis Use Disorder Treatment Product Offered &nbsp;11.2.3 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Alkermes Main Business Overview &nbsp;11.2.5 Alkermes Latest Developments &nbsp;11.3 BioCorRx &nbsp;11.3.1 BioCorRx Company Information &nbsp;11.3.2 BioCorRx Cannabis Use Disorder Treatment Product Offered &nbsp;11.3.3 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 BioCorRx Main Business Overview &nbsp;11.3.5 BioCorRx Latest Developments &nbsp;11.4 Cipla Limited &nbsp;11.4.1 Cipla Limited Company Information &nbsp;11.4.2 Cipla Limited Cannabis Use Disorder Treatment Product Offered &nbsp;11.4.3 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Cipla Limited Main Business Overview &nbsp;11.4.5 Cipla Limited Latest Developments &nbsp;11.5 Dr. Reddyï¿½s Laboratories &nbsp;11.5.1 Dr. Reddyï¿½s Laboratories Company Information &nbsp;11.5.2 Dr. Reddyï¿½s Laboratories Cannabis Use Disorder Treatment Product Offered &nbsp;11.5.3 Dr. Reddyï¿½s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Dr. Reddyï¿½s Laboratories Main Business Overview &nbsp;11.5.5 Dr. Reddyï¿½s Laboratories Latest Developments &nbsp;11.6 Glenmark Pharmaceuticals Limited &nbsp;11.6.1 Glenmark Pharmaceuticals Limited Company Information &nbsp;11.6.2 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered &nbsp;11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Glenmark Pharmaceuticals Limited Main Business Overview &nbsp;11.6.5 Glenmark Pharmaceuticals Limited Latest Developments &nbsp;11.7 Intas Pharmaceuticals Limited &nbsp;11.7.1 Intas Pharmaceuticals Limited Company Information &nbsp;11.7.2 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered &nbsp;11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Intas Pharmaceuticals Limited Main Business Overview &nbsp;11.7.5 Intas Pharmaceuticals Limited Latest Developments &nbsp;11.8 Indivior &nbsp;11.8.1 Indivior Company Information &nbsp;11.8.2 Indivior Cannabis Use Disorder Treatment Product Offered &nbsp;11.8.3 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Indivior Main Business Overview &nbsp;11.8.5 Indivior Latest Developments &nbsp;11.9 Mallinckrodt &nbsp;11.9.1 Mallinckrodt Company Information &nbsp;11.9.2 Mallinckrodt Cannabis Use Disorder Treatment Product Offered &nbsp;11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Mallinckrodt Main Business Overview &nbsp;11.9.5 Mallinckrodt Latest Developments &nbsp;11.10 Noramco &nbsp;11.10.1 Noramco Company Information &nbsp;11.10.2 Noramco Cannabis Use Disorder Treatment Product Offered &nbsp;11.10.3 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Noramco Main Business Overview &nbsp;11.10.5 Noramco Latest Developments &nbsp;11.11 Orexo AB &nbsp;11.11.1 Orexo AB Company Information &nbsp;11.11.2 Orexo AB Cannabis Use Disorder Treatment Product Offered &nbsp;11.11.3 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Orexo AB Main Business Overview &nbsp;11.11.5 Orexo AB Latest Developments &nbsp;11.12 Purdue Pharma &nbsp;11.12.1 Purdue Pharma Company Information &nbsp;11.12.2 Purdue Pharma Cannabis Use Disorder Treatment Product Offered &nbsp;11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Purdue Pharma Main Business Overview &nbsp;11.12.5 Purdue Pharma Latest Developments 12 Research Findings and Conclusion

Buyer Information

Order Summary

Report	Global Cannabis Use Disorder Treatment Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI39897